A sham-controlled clinical trial to examine the effect of bilateral tDCS on craving, TNF-α and IL-6 expression levels, and impulsivity of males with opioid use disorder

References

• Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30(2):155–66. doi:10.1016/j.cpr.2009.10.006.
   PubMed Web of Science ®Google Scholar
• Amercian Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC, United States: American Psychiatric Association Publishing, 2013.
   Google Scholar
• John WS, Zhu H, Mannelli P, Schwartz RP, Subramaniam GA, Wu LT. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Drug Alcohol Depend. 2018;187:79–87. doi:10.1016/j.drugalcdep.2018.01.035.
   PubMed Web of Science ®Google Scholar
• Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–68. doi:10.1056/NEJMra1604339.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry. 2019;76(2):208–16. doi:10.1001/jamapsychiatry.2018.3126.
   PubMed Web of Science ®Google Scholar
• Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag. 2014;17(6):372–87. doi:10.1089/pop.2013.0098.
   PubMed Web of Science ®Google Scholar
• Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, Hefazi M, Motevalian A. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016;111(10):1836–47. doi:10.1111/add.13453.
   PubMed Web of Science ®Google Scholar
• Winstanley CA, Olausson P, Taylor JR, Jentsch JD. Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res. 2010;34(8):1306–18. doi:10.1111/j.1530-0277.2010.01215.x.
   PubMed Web of Science ®Google Scholar
• Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783–93. doi:10.1176/appi.ajp.158.11.1783.
   PubMed Web of Science ®Google Scholar
• Gilmore C, Dickmann P, Lamberty G, Armstrong M, Lim K. Reducing impulsivity with transcranial direct current stimulation (tDCS) and a cognitive task. Biol Psychiatry. 2017;81(10):S214–S215. doi:10.1016/j.biopsych.2017.02.1137.
   Web of Science ®Google Scholar
• Teti Mayer J, Nicolier M, Gabriel D, Masse C, Giustiniani J, Compagne C, Vandel P, Pazart L, Haffen E, Bennabi D, et al. Efficacy of transcranial direct current stimulation in reducing impulsivity in borderline personality disorder (TIMBER): study protocol of a randomized controlled clinical trial. Trials. 2019;20(1):347. doi:10.1186/s13063-019-3427-z.
   PubMedGoogle Scholar
• Toskulkao T, Pornchai R, Akkarapatumwong V, Vatanatunyakum S, Govitrapong P. Alteration of lymphocyte opioid receptors in methadone maintenance subjects. Neurochem Int. 2010;56(2):285–90. doi:10.1016/j.neuint.2009.10.013.
   PubMed Web of Science ®Google Scholar
• Asadikaram G, Igder S, Jamali Z, Shahrokhi N, Najafipour H, Shokoohi M, Jafarzadeh A, Kazemi-Arababadi M. Effects of different concentrations of opium on the secretion of interleukin-6, interferon-γ and transforming growth factor beta cytokines from jurkat cells. Addict Health. 2015;7(1–2):47–53.
   PubMedGoogle Scholar
• Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Daneshmandi S, Shamsizadeh A, Kennedy D. Non-association of IL-12 + 1188 and IFN-γ +874 polymorphisms with cytokines serum level in occult HBV infected patients. Saudi J Gastroenterol. 2011;17(1):30–5. doi:10.4103/1319-3767.74461.
   PubMed Web of Science ®Google Scholar
• Arababadi MK. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iran J Kidney Dis. 2010;4(4):302–6.
   PubMed Web of Science ®Google Scholar
• Chan Y-Y, Yang S-N, Lin J-C, Chang J-L, Lin J-G, Lo W-Y. Inflammatory response in heroin addicts undergoing methadone maintenance treatment. Psychiatry Res. 2015;226(1):230–4. doi:10.1016/j.psychres.2014.12.053.
   PubMed Web of Science ®Google Scholar
• Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254–66. doi:10.7150/ijbs.4679.
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54(11):3551–633. doi:10.1002/art.22175.
   PubMed Web of Science ®Google Scholar
• Favalli EG. Understanding the role of interleukin-6 (IL-6) in the joint and beyond: a comprehensive review of il-6 inhibition for the management of rheumatoid arthritis. Rheumatol Ther. 2020;7(3):473–516. doi:10.1007/s40744-020-00219-2.
   PubMed Web of Science ®Google Scholar
• Sergio N, Salvatore T, Gaetano B, Davide P, Claudio I, Massimo L, Barbara M, Giuseppe A, Stefano C, Danila C, et al. Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin. J Gastroenterol Hepatol. 2007;22(1):74–9. doi:10.1111/j.1440-1746.2006.04423.x.
   PubMed Web of Science ®Google Scholar
• Farajzadeh D, Karimi-Gharigh S, Dastmalchi S. Tumor necrosis factor-alpha and its inhibition strategies: review article. Tehran Univ Med J. 2017;75(3):159–71.
   Google Scholar
• Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453–62. doi:10.1002/glia.20467.
   PubMed Web of Science ®Google Scholar
• Chu N, Xia W, Yu P, Hu L, Zhang R, Cui C. Chronic morphine-induced neuronal morphological changes in the ventral tegmental area in rats are reversed by electroacupuncture treatment . Addict Biol. 2008;13(1):47–51. doi:10.1111/j.1369-1600.2007.00092.x.
   PubMed Web of Science ®Google Scholar
• Dunn AJ. The HPA axis and the immune system: a perspective. Neuroimmune Biol. 2007;7:3–15.
   Google Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005;67(4):1216–33. doi:10.1111/j.1523-1755.2005.00200.x.
   PubMed Web of Science ®Google Scholar
• Yende S, Tuomanen EI, Wunderink R, Kanaya A, Newman AB, Harris T, De Rekeneire N, Kritchevsky SB. Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med. 2005;172(11):1440–6. doi:10.1164/rccm.200506-888OC.
   PubMed Web of Science ®Google Scholar
• Woo YR, Park CJ, Kang H, Kim JE. The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic. Int J Mol Sci. 2020;21(19):7041. doi:10.3390/ijms21197041.
   PubMed Web of Science ®Google Scholar
• Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, Pugliese D, Papa A, Mocci G, De Vitis I, et al. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. J Crohns Colitis. 2013;7(4):301–7. doi:10.1016/j.crohns.2012.05.011.
   PubMed Web of Science ®Google Scholar
• Moberg K. The role of managed care professionals and pharmacists in combating opioid abuse. Am J Manag Care. 2018;24(10 Suppl):S215–S223.
   PubMed Web of Science ®Google Scholar
• Szalavitz M, Rigg KK. The curious (dis)connection between the opioid epidemic and crime. Subst Use Misuse. 2017;52(14):1927–31. doi:10.1080/10826084.2017.1376685.
   PubMed Web of Science ®Google Scholar
• Dydyk AM, Jain NK, Gupta M. Opioid use disorder. Island, FL: StatPearls Publishing, 2020.
   Google Scholar
• Luigjes J, Segrave R, de Joode N, Figee M, Denys D. Efficacy of invasive and non-invasive brain modulation interventions for addiction. Neuropsychol Rev. 2019;29(1):116–38. doi:10.1007/s11065-018-9393-5.
   PubMed Web of Science ®Google Scholar
• George O, Koob GF. Control of craving by the prefrontal cortex. Proc Natl Acad Sci U S A. 2013;110(11):4165–6. doi:10.1073/pnas.1301245110.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Ko JH, Strafella AP, Dagher A. Dorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette craving. Proc Natl Acad Sci U S A. 2013;110(11):4422–7. doi:10.1073/pnas.1212185110.
   PubMed Web of Science ®Google Scholar
• Varoli E, Pisoni A, Mattavelli GC, Vergallito A, Gallucci A, Mauro LD, Rosanova M, Bolognini N, Vallar G, Romero Lauro LJ, et al. Tracking the effect of cathodal transcranial direct current stimulation on cortical excitability and connectivity by means of TMS-EEG. Front Neurosci. 2018;12:319. doi:10.3389/fnins.2018.00319.
   PubMed Web of Science ®Google Scholar
• Bai Y, Xia X, Kang J, Yang Y, He J, Li X. TDCS modulates cortical excitability in patients with disorders of consciousness. Neuroimage Clin. 2017;15:702–9. doi:10.1016/j.nicl.2017.01.025.
   PubMed Web of Science ®Google Scholar
• Mondino M, Bennabi D, Poulet E, Galvao F, Brunelin J, Haffen E. Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders? World J Biol Psychiatry. 2014;15(4):261–75. doi:10.3109/15622975.2013.876514.
   PubMed Web of Science ®Google Scholar
• Taremian F, Nazari S, Moradveisi L, Moloodi R. Transcranial direct current stimulation on opium craving, depression, and anxiety: a preliminary study. J ECT. 2019;35(3):201–6. doi:10.1097/YCT.0000000000000568.
   PubMed Web of Science ®Google Scholar
• Gonçalves EM. Stress prevention by modulation of autonomic nervous system (heart rate variability): A preliminary study using transcranial direct current stimulation. Open J Psychiatry. 2012;2(2):113–22.
   Google Scholar
• Moradi Kelardeh S, Yaryari F, Abdollahi MH. Effectiveness of Transcranial direct current stimulation on Dorsolateral prefrontal cortex in cigarette craving and Stress. J Res Psychol Health. 2016;10(3):30–7.
   Google Scholar
• Gorini A, Lucchiari C, Russell-Edu W, Pravettoni G. Modulation of risky choices in recently abstinent dependent cocaine users: a transcranial direct-current stimulation study. Front Hum Neurosci. 2014;8:661 doi:10.3389/fnhum.2014.00661.
   PubMed Web of Science ®Google Scholar
• Sadeghi Movahed F, Alizadeh Goradel J, Pouresmali A, Mowlaie M. Effectiveness of transcranial direct current stimulation on worry, anxiety, and depression in generalized anxiety disorder: A randomized, single-blind pharmacotherapy and sham-controlled clinical trial. Iran J Psychiatry Behav Sci. 2018;12(2):e11071. doi:10.5812/ijpbs.11071.
   Web of Science ®Google Scholar
• McClintock SM, Martin DM, Lisanby SH, Alonzo A, McDonald WM, Aaronson ST, Husain MM, O'Reardon JP, Weickert CS, Mohan A, et al. Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial. Depress Anxiety. 2020;37(3):261–72. doi:10.1002/da.22988.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shen Y, Cao X, Shan C, Pan J, He H, Ma Y, Yuan T-F. Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates cue-induced craving for heroin. J Psychiatr Res. 2016;79:1–3. doi:10.1016/j.jpsychires.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Batista EK, Klauss J, Fregni F, Nitsche MA, Nakamura-Palacios EA. Randomized placebo-controlled trial of targeted prefrontal cortex modulation with bilateral tDCS in patients with crack-cocaine dependence. Int J Neuropsychopharmacol. 2015;18(12):pyv066. doi:10.1093/ijnp/pyv066.
   PubMed Web of Science ®Google Scholar
• Chaudhari SS, Somvanshi PR, Fregni F. Transcranial direct current stimulation for opioid use disorder: protocol for a pilot randomized controlled trial. Principles Pract Clin Res. 2019;5(2):45–51. doi:10.21801/ppcrj.2019.52.3.
   Google Scholar
• Lupi M, Martinotti G, Santacroce R, Cinosi E, Carlucci M, Marini S, Acciavatti T, di Giannantonio M. Transcranial direct current stimulation in substance use disorders: a systematic review of scientific literature. J ECT. 2017;33(3):203–9. doi:10.1097/YCT.0000000000000401.
   PubMed Web of Science ®Google Scholar
• Young JR, Smani SA, Mischel NA, Kritzer MD, Appelbaum LG, Patkar AA. Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature. J Addict Dis. 2020;38(2):186–99. doi:10.1080/10550887.2020.1736756.
   PubMed Web of Science ®Google Scholar
• Franken IH, Hendriks VM, Van Den Brink W. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav. 2002;27(5):675–85. doi:10.1016/s0306-4603(01)00201-5.
   PubMed Web of Science ®Google Scholar
• Hassani-Abharian P, Mokri A, Ganjgahi H, Oghabian MA, Ekhtiari H. Validation for Persian version of desire for drug questionnaire and obsessive compulsive drug use scale in heroin dependents. Arch Iran Med. 2016;19(9):659–65.
   PubMed Web of Science ®Google Scholar
• Patton JH, Stanford MS, Barratt ES. Factor structure of the barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–74. doi:10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1.
   PubMed Web of Science ®Google Scholar
• Ekhtiari H, Safaei H, Esmaeeli Djavid G, Atefvahid MK, Edalati H, Mokri A. Reliability and validity of Persian versions of Eysenck, Barratt, Dickman and Zuckerman Questionnaires in assessing risky and impulsive behaviors. Iran J Psychiatry Clin Psychol. 2008;14(3):326–36.
   Google Scholar
• De Almeida Ramos R, Taiar I, Trevizol AP, Shiozawa P, Cordeiro Q. Effect of a ten-day prefrontal transcranial direct current stimulation protocol for crack craving: a proof-of-concept trial. J ECT. 2016;32(3):e8–e9. doi:10.1097/YCT.0000000000000302.
   PubMed Web of Science ®Google Scholar
• Haddar A, Zangen A. Brain stimulation as a novel technique for craving management and the treatment of addiction. In: Wilson SJ, editor. The wiley handbook on the cognitive neuroscience of addiction. Chichester, UK: John Wiley & Sons, 2015.
   Google Scholar
• Labbe S, Fecteau S. impulsivity and substance-use disorders. In: Brunoni A, Nitsche M, Loo C, editors. Transcranial direct current stimulation in neuropsychiatric disorders: clinical principles and management. Switzerland: Springer; 2016. p. 281–91.
   Google Scholar
• Spezia Adachi LN, Caumo W, Laste G, Fernandes Medeiros L, Ripoll Rozisky J, de Souza A, Fregni F, Torres ILS. Reversal of chronic stress-induced pain by transcranial direct current stimulation (tDCS) in an animal model. Brain Res. 2012;1489:17–26. doi:10.1016/j.brainres.2012.10.009.
   PubMed Web of Science ®Google Scholar
• Pruett SB. Effects of drugs of abuse on cytokine responses. In: House RV, Descotes J., editors. Cytokines in human health. Methods in pharmacology and toxicology. NY, United States: Humana Press, 2007, pp.133–173.
   Google Scholar